EJNMMI Research · 2019 · 22 citations · 30 references
MedicineOncologyRadiologyDiagnostic ImagingDiagnostic Nuclear MedicineDiagnostic RadiologyEndocrine Tumor DiagnosisEndocrine Tumor ImagingNeuroendocrine Tumor SurgeryNeuroendocrine TumorsPositron Emission TomographyTumor DetectionDiagnostic Accuracy StudiesDiagnostic Testing AccuracyEndoscopic UltrasonographyNeuroendocrine Tumor HistologyOncologic Pet ImagingPancreatic Neuroendocrine NeoplasmsPancreatic Neuroendocrine Tumor DiagnosisPancreatic Neuroendocrine Tumor Imaging
Abstract Background Predicting the aggressive behavior of non-functional pancreatic neuroendocrine tumors (NF-PNET) remains controversial. We wanted to explore, in a prospective setting, whether the diagnostic accuracy can be improved by dual-tracer functional imaging 68 Ga-DOTANOC and 18 F-FDG-PET/CT in patients with NF-PNETs. Methods Thirty-one patients with NF-PNET (90% asymptomatic) underwent PET-imaging with 18 F-FDG and 68 Ga-DOTANOC, followed by surgery ( n = 20), an endoscopic ultrasonography and fine-needle biopsy ( n = 2) or follow-up ( n = 9). A focal activity on PET/CT greater than the background that could not be identified as physiological activity was considered to indicate tumor tissue. The imaging results were compared to histopathology. The mean follow-up time was 31.3 months. Results Thirty-one patients presented a total of 53 lesions (40 histologically confirmed) on PET/CT. Thirty patients had a 68 Ga-DOTANOC-positive tumor (sensitivity 97%) and 10 patients had an 18 F-FDG-positive tumor. In addition, one 68 Ga-DOTANOC-negative patient was 18 F-FDG-positive. 18 F-FDG-PET/CT was positive in 19% (3/16) of the G1 tumors, 63% (5/8) of the G2 tumors and 1/1 of the well-differentiated G3 tumor. 68 Ga-DOTANOC-PET/CT was positive in 94% of the G1 tumors, 100% of the G2 tumors and 1/1 of the well-differentiated G3 tumor. Two out of six (33%) of the patients with lymph node metastases (LN+) were 18 F-FDG-positive. The 18 F-FDG-PET/CT correlated with tumor Ki-67 ( P = 0.021). Further, the Krenning score correlated with tumor Ki-67 ( P = 0.013). 18 F-FDG-positive tumors were significantly larger than the 18 F-FDG-negative tumors ( P = 0.012). 18 F-FDG-PET/CT showed a positive predictive value of 78% in the detection of potentially aggressive tumors (G2, G3, or LN + PNETs); the negative predictive value was 69%. Conclusions 18 F-FDG-PET/CT is useful to predict tumor grade but not the LN+ of NF-PNETs. Patients with 18 F-FDG-avid NF-PNETs should be referred for surgery. The 68 Ga-DOTANOC-PET/CT also has prognostic value since the Krenning score predicts the histopathological tumor grade. Trial registration The study has been registered at ClinicalTrials.gov ; Non-functional Pancreatic NET and PET imaging, NCT02621541 .
30
Massimo Falconi, Barbro Eriksson, Gregory Kaltsas et al. · Neuroendocrinology · 2016 · 1.4K citations · Full text
Medicine, Endocrinology, Oncology +17
Vilppu J. Tuominen, Sanna Ruotoistenmäki, Arttu Viitanen et al. · Breast Cancer Research · 2010 · 469 citations · Full text
Medicine, Cancer Biology, Oncology +14
Irene Virgolini, Valentina Ambrosini, Jamshed Bomanji et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 447 citations